NovoCure Limited ( NVCR) - Key Metrics
NVCR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.56 | -$0.22 | -$0.16 | -$0.21 |
| 2025Q3 | $1.49 | -$0.33 | $0.18 | $0.13 |
| 2025Q2 | $1.42 | -$0.36 | -$0.14 | -$0.19 |
| 2025Q1 | $1.41 | -$0.31 | -$0.32 | -$0.42 |
NVCR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -14.71 |
| 2025Q3 | ? | -9.70 |
| 2025Q2 | ? | -12.37 |
| 2025Q1 | ? | -14.32 |
NVCR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -1.50% | ? |
| 2025Q4 | -1.59% | ? |
| 2025Q3 | 1.03% | ? |
| 2025Q2 | -1.08% | ? |
| 2025Q1 | -2.35% | ? |
NVCR
Price: $16.15
52 week price:
Earnings Per Share: -1.53 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: Jersey
Volume: 542600
Ebitda: -3.9 millionMarket Capitalization: 2.0 billion